首页> 外国专利> USE OF COMPOUNDS THAT ARE ABLE TO INCREASE THE SERUM IGF-1 LEVEL FOR THE PREPARATION OF A THERAPEUTICAL COMPOSITION FOR TREATMENT OF VARIOUS DISEASE STATES ASSOCIATED WITH A REDUCED IGF-1 SERUM LEVEL IN HUMANS AND ANIMALS

USE OF COMPOUNDS THAT ARE ABLE TO INCREASE THE SERUM IGF-1 LEVEL FOR THE PREPARATION OF A THERAPEUTICAL COMPOSITION FOR TREATMENT OF VARIOUS DISEASE STATES ASSOCIATED WITH A REDUCED IGF-1 SERUM LEVEL IN HUMANS AND ANIMALS

机译:使用可增加血清IGF-1水平的化合物制备治疗与人类和动物体内IGF-1血清水平降低有关的各种疾病的治疗性组合物

摘要

The present disclosure relates to the use of one or more compounds that are capable of increasing the serum level of insulin-like growth factor 1 (IGF-1) for the preparation of a therapeutical composition, in particular, in the form of a food supplement, for the treatment of subjects suffering from serious fatigue and exhausting symptoms, burn-out and chronic fatigue syndrome. The same composition can also be used by patients suffering from depression, Alzheimer disease, irritated bowel syndrome, osteoporosis, type 2 diabetes, or for anti-aging, immune therapy and recovery after exercise. The composition also has a use in veterinary applications for increasing the growth and immunity in animals.
机译:本公开涉及一种或多种能够增加胰岛素样生长因子1(IGF-1)的血清水平的化合物在制备治疗组合物中的用途,特别是以食物补充剂的形式。 ,用于治疗患有严重疲劳和疲惫症状,倦怠和慢性疲劳综合症的对象。患有抑郁症,阿尔茨海默氏病,肠激惹综合症,骨质疏松症,2型糖尿病的患者也可以使用相同的成分,或用于抗衰老,免疫疗法和运动后恢复。该组合物在兽医应用中也可用于增加动物的生长和免疫力。

著录项

  • 公开/公告号US2016331725A1

    专利类型

  • 公开/公告日2016-11-17

    原文格式PDF

  • 申请/专利权人 VEIJLEN N.V.;

    申请/专利号US201615203671

  • 申请日2016-07-06

  • 分类号A61K31/405;A61K9/48;A61K47/48;

  • 国家 US

  • 入库时间 2022-08-21 13:49:04

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号